Real-world evaluation of atezolizumab and etoposide-carboplatin as a first-line treatment for extensive-stage small cell lung cancer

BACKGROUND/AIMS: Despite the obvious benefits of adding immune checkpoint inhibitors to platinum-etoposide chemotherapy in patients with extensive-stage small-cell lung cancer (ES-SCLC), real-world data remain scarce. METHODS: This retrospective study included 89 patients with ES-SCLC treated with p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Soo Han, Jo, Eun Jung, Mok, Jeongha, Lee, Kwangha, Kim, Ki Uk, Park, Hye-Kyung, Lee, Min Ki, Eom, Jung Seop, Kim, Mi-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993105/
https://www.ncbi.nlm.nih.gov/pubmed/36800677
http://dx.doi.org/10.3904/kjim.2022.361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993105/
https://www.ncbi.nlm.nih.gov/pubmed/36800677
http://dx.doi.org/10.3904/kjim.2022.361

Ejemplares similares